By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Tokyo      Japan
Phone: 81-3-3485-7707 Fax: n/a



Company News
Peptidream And Kleo Announce Collaboration Agreement To Develop Novel Immunotherapies For Oncology 7/18/2017 6:54:52 AM
Heptares And Peptidream Enter Strategic Collaboration To Discover, Develop And Commercialise Novel Therapeutics In Inflammatory Disease 6/29/2017 8:46:44 AM
Peptidream Announces Licensing Of Peptide Discovery Platform System (PDPS) Technology To Shionogi 6/12/2017 8:21:07 AM
Johnson & Johnson (JNJ) Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream 4/7/2017 6:05:27 AM
Peptidream Announces License Of PDPS Technology To Genentech (RHHBY) 7/20/2016 11:23:14 AM
Peptidream Co-Founder's Long Road: From Failed Guitarist to $3 Billion Drug Firm 6/20/2016 6:33:32 AM
Peptidream Achieves Milestone For Initiation Of Clinical Development For Bristol-Myers Squibb (BMY)’s First Collaboration Product Candidate 6/15/2016 8:20:52 AM
Peptidream Announces Research Collaboration With BIND Therapeutics (BIND) 4/6/2016 10:17:10 AM
Peptidream Announces License Of PDPS Technology To Eli Lilly (LLY) 3/7/2016 12:21:18 PM
Teijin Pharma To Collaborate With Peptidream In Peptide Discovery 9/28/2015 9:59:20 AM